• English (United Kingdom)
  • Italiano (Italia)
    • + Increase
    • - Decrease
    • = Normal
    • Default mode
    • High Contrast
    • High Contrast
    • Aa
Registro Tumori Veneto
  • Home
  • About us
    • Introduction
    • Staff
    • Population and area
    • Statement
    • News
    • Mesotelioma Registry
      • Governance
        • Methods
        • Statement
      • Activities
      • Staff
      • Publications
  • Data
    • Veneto Data
    • Tumour site data
    • ULSS Data
  • Publications
    • Research publications
    • Meetings
      • Oral presentations
      • Posters
  • Links
  • Contacts
Registro Tumori Veneto
  • Home
  • About us
    • Introduction
    • Staff
    • Population and area
    • Statement
    • News
    • Mesotelioma Registry
      • Governance
        • Methods
        • Statement
      • Activities
      • Staff
      • Publications
  • Data
    • Veneto Data
    • Tumour site data
    • ULSS Data
  • Publications
    • Research publications
    • Meetings
      • Oral presentations
      • Posters
  • Links
  • Contacts

  • Prognosis for Cutaneous Melanoma by Clinical and Pathological Profile: A Population-Based Study

  • Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

  • Quality management of cutaneous melanoma: impact on short-term outcomes and costs

  • Rare cancers are not so rare: the rare cancer burden in Europe

  • Rare thoracic cancers, including peritoneum mesothelioma

  • Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study

  • Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs

  • Sex Differences in Soft Tissue Sarcoma: Incidence, Clinicopathological Profile, Survival, and Costs

  • Survival data updated

  • Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: results from EUROCARE-5

  • Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: results of EUROCARE-5

  • Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5

  • Survival of adults with primary malignant brain tumours in Europe: results of the EUROCARE-5 study

  • Survival of cancer patients in Italy

  • Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: results from the EUROCARE-5 study

  • Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study

  • Survival patterns in lung and pleural cancer in Europe 1999-2007: results from the EUROCARE-5 study

  • Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: results of EUROCARE-5 population-based study

  • Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference

  • The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project

Page 3 of 4

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next
  • End

Copyright © Registro Tumori Veneto 2018

Powered by ict4Life 

Privacy Policy

Joomla Templates by Joomla-Monster.com
Back to top